Molecular testing for the factor V-Leiden mutation in the clinical laboratory

Authors
Citation
Sg. Spitzer, Molecular testing for the factor V-Leiden mutation in the clinical laboratory, LAB MED, 30(10), 1999, pp. 681-683
Citations number
13
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology
Journal title
LABORATORY MEDICINE
ISSN journal
00075027 → ACNP
Volume
30
Issue
10
Year of publication
1999
Pages
681 - 683
Database
ISI
SICI code
0007-5027(199910)30:10<681:MTFTFV>2.0.ZU;2-U
Abstract
Activated protein C (APC) resistance is a major cause of deep venous thromb osis. Most cases of APC resistance are due to a variant of factor V (FV), k nown as FV-Leiden, that is resistant to degradation by APC. The FV-Leiden m utation can be detected by a simple and reliable polymerase chain reaction method. During the past year we tested 355 patients for FV-Leiden. Twenty-s ix were heterozygous, and 3 were homozygous for the mutation. The prevalenc e of FV-Leiden was substantially higher in patients <30 years of age.